Stock Events

Stock Events

Enveric Biosciences 

$2.17
0
-$0.23-9.58% Today

Statistics

Day High
2.17
Day Low
2.17
52W High
-
52W Low
-
Volume
2
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

26MarExpected
Q3 2025
Next
-63
-45.6
-28.21
-10.81
Expected EPS
-55.8
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ENVB.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Corbus Pharmaceuticals works on developing and commercializing novel therapeutics to treat inflammatory and fibrotic diseases, overlapping with Enveric's target indications.
Aurora Cannabis
ACB
Mkt Cap280.01M
Aurora Cannabis is a major player in the cannabis industry, potentially competing in the medical cannabis space where Enveric operates.
Tilray Brands
TLRY
Mkt Cap1.5B
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially overlapping with Enveric's market in cannabinoid-based therapeutics.
Canopy Growth
CGC
Mkt Cap418.51M
Canopy Growth Corporation operates in the cannabis and hemp business, directly competing in the broader market for cannabinoid-based products.

About

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Show more...
CEO
Dr. Joseph Edward Tucker Ph.D.
Employees
7
Country
US
ISIN
US29405E5050

Listings

F
DE
SLZ0.F
XNAS
US
ENVB
BOATS
BOATS
ENVB.BOATS

0 Comments

Share your thoughts

FAQ

What is Enveric Biosciences stock price today?▼
The current price of ENVB.BOATS is $2.17 USD — it has decreased by -9.58% in the past 24 hours. Watch Enveric Biosciences stock price performance more closely on the chart.
What is Enveric Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Enveric Biosciences stocks are traded under the ticker ENVB.BOATS.
When is the next Enveric Biosciences earnings date?▼
Enveric Biosciences is going to release the next earnings report on March 26, 2026.
What were Enveric Biosciences earnings last quarter?▼
ENVB.BOATS earnings for the last quarter are -10.81 USD per share, whereas the estimation was -63 USD resulting in a +82.84% surprise. The estimated earnings for the next quarter are N/A USD per share.
How many employees does Enveric Biosciences have?▼
As of February 10, 2026, the company has 7 employees.
In which sector is Enveric Biosciences located?▼
Enveric Biosciences operates in the Health Care sector.
When did Enveric Biosciences complete a stock split?▼
Enveric Biosciences has not had any recent stock splits.
Where is Enveric Biosciences headquartered?▼
Enveric Biosciences is headquartered in Naples, US.